isradipine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sen, AP | 1 |
| Boksa, P | 1 |
| Quirion, R | 1 |
| Watson, DL | 1 |
| Carpenter, CL | 1 |
| Marks, SS | 1 |
| Greenberg, DA | 1 |
2 other studies available for isradipine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases.
Topics: Aged; Alzheimer Disease; Autopsy; Binding Sites; Brain; Calcium; Calcium Channels; Dihydropyridines; | 1993 |
Striatal calcium channel antagonist receptors in Huntington's disease and Parkinson's disease.
Topics: Aged; Calcium Channel Blockers; Corpus Striatum; Humans; Huntington Disease; Isradipine; Middle Aged | 1988 |